Newsroom
For media inquiries, please contact 340B Health Senior VP of Communications Richard Sorian at richard.sorian@340bhealth.org or 202-536-2285.
-
STATEMENT ON NEW DRUG COMPANY LAWSUITS TARGETING THE 340B PROGRAM
-
340B HEALTH AND ALLIES DEMAND THAT MANUFACTURERS DISCONTINUE ILLEGAL DRUG PRICING PRACTICES
-
340B HEALTH BOARD ELECTS TWO NEW MEMBERS
-
STATEMENT ON HHS GENERAL COUNSEL’S ADVISORY OPINION ON 340B CONTRACT PHARMACIES
-
HOSPITALS AND PHARMACISTS FILE LAWSUIT OVER DRUG COMPANIES’ REFUSALS OF 340B DISCOUNTS
-
STATEMENT ON HRSA’S FINAL 340B ADMINISTRATIVE DISPUTE RESOLUTION RULE
-
STATEMENT ON FINALIZED MEDICARE CUTS TO 340B HOSPITALS IN 2021
-
STATEMENT ON NOVO NORDISK CUTTING OFF ACCESS TO 340B PRICING THROUGH COMMUNITY-BASED PHARMACIES
-
NEARLY HALF OF U.S. HOUSE MEMBERS OPPOSE MOVE TO CONVERT 340B INTO A REBATE PROGRAM
-
STATEMENT REGARDING NOVARTIS CUTTING OFF ACCESS TO 340B PRICING THROUGH COMMUNITY-BASED PHARMACIES
-
COMMENT LETTER TO CMS CALLS FOR SCRAPPING PROPOSAL TO DEEPEN MEDICARE CUTS TO 340B HOSPITALS IN 2021
-
STATEMENT ON ASTRAZENECA AND SANOFI DENIALS OF 340B PRICING TO SAFETY-NET HOSPITALS